Telus Peptides

Ovagen

Bioregulators Research compound (not approved for human use)

Synthetic tripeptide bioregulator (Glu-Asp-Leu) · also known as EDL, Glu-Asp-Leu

For reference only — not medical advice. Figures are commonly reported values compiled from published sources and may be wrong or out of date. Many compounds listed are not approved for human use. Talk to a licensed clinician before using any compound.

Ovagen has a very small literature. It was studied alongside the AED tripeptide in aging kidney cell cultures, and reviews associate it with renal and liver cell function. Human evidence for the vial protocol is absent.

Commonly reported dosing (20 mg vial)

Reconstituted with 2 mL → 10 mg/mL.

PhaseDoseVolumeU-100 units
Standard
Below about 2 units on a U-100 syringe at this concentration; not reliably measurable.
100 mcg0.01 mL1
Higher
Below about 2 units on a U-100 syringe at this concentration; not reliably measurable.
150 mcg0.015 mL1.5

Frequency: Once daily, subcutaneous (up to 16 weeks with gradual escalation, community-reported) · Half-life: Not well characterized in the published literature

Open in calculator

Commonly reported reconstitution steps

  1. Vials are usually brought to room temperature (about 15-20 minutes) first.
  2. 2 mL of bacteriostatic water is added slowly down the inside wall of the 20 mg vial.
  3. The vial is swirled gently until clear, not shaken.
  4. This gives 10 mg/mL. Mixed vials are typically labeled with the date and refrigerated.

Storage

Before mixing: Lyophilized vials are commonly stored frozen (about -20 °C), dry, and protected from light.

After mixing: Reconstituted solution is commonly kept refrigerated (2-8 °C), protected from light, and freeze-thaw cycles are commonly avoided.

How it works

Computer models and cell work suggest it may bind AT-rich sequences in the DNA minor groove and shift expression of senescence markers (p16, p21, p53, SIRT-6) in kidney cells; this is hypothesized.

Researched for

  • Studied in young and aged renal cell cultures for proliferation and senescence markers.
  • Described in reviews as a renal-cell and hepatoprotective bioregulator.

Notes

  • Unlike the other 3 mL entries, the reference lists 2 mL of diluent, giving about 10 mg/mL; the early amounts (10-20 mcg) correspond to 0.001-0.002 mL, below what a standard U-100 syringe can reliably resolve.
  • Evidence comes largely from a single research group (Khavinson and colleagues, St. Petersburg), mostly cell-culture and animal work; independent replication and controlled human trials are scarce.
  • Published human work from the originating group has mostly used oral or other non-vial formats; the vial, reconstitution and dosing figures here reflect community-reported conventions rather than trial-validated regimens.
  • Not FDA-approved.

Sources

Last reviewed 2026-10-06.

Related

Cartalax

Synthetic tripeptide bioregulator (Ala-Glu-Asp)

Cartalax is a three-residue peptide (alanine, glutamate, aspartate) studied by the Khavinson group in connection with cartilage and connective tissue.

20 mg vial · Once daily, subcutaneous (8-12 week courses, community-reported)

Livagen

Synthetic tetrapeptide bioregulator (Lys-Glu-Asp-Ala)

Livagen is a four-residue peptide (lysine, glutamate, aspartate, alanine) studied by the Khavinson group, with a liver-oriented label.

20 mg vial · Once daily, subcutaneous (8-12 week courses, community-reported)

Vesugen

Synthetic tripeptide bioregulator (Lys-Glu-Asp)

Vesugen is a three-residue peptide (lysine, glutamate, aspartate) from the Khavinson family, associated with blood vessels and the cardiovascular system.

20 mg vial · Once daily, subcutaneous (8-12 week courses, community-reported)

Pinealon

Synthetic tripeptide bioregulator (Glu-Asp-Arg)

Pinealon is a three-residue peptide (glutamate, aspartate, arginine) developed by the Khavinson group as a brain-oriented bioregulator.

20 mg vial · Once daily, subcutaneous, in 10-20 day courses (community-reported)

Epitalon

Synthetic tetrapeptide (Ala-Glu-Asp-Gly)

Epitalon is a four-amino-acid synthetic peptide modelled on a pineal gland extract and studied for telomerase activity and aging biology.

10 mg vial · Once daily for about 20 days, subcutaneous

Prostamax

Synthetic tetrapeptide bioregulator (Lys-Glu-Asp-Pro)

Prostamax is a four-residue peptide (lysine, glutamate, aspartate, proline) from the Khavinson family, associated with prostate tissue.

20 mg vial · Once daily, usually intramuscular with subcutaneous as an alternative (8-12 week courses, community-reported)